Janux Therapeutics, Inc. (NASDAQ:JANX) has 174 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 349,206 | 9.36% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Prosight Management, LP | 31 Dec, 2025 | 0 | 1,527,173 | 176.48% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -96,852 | -30.45% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 649,341 | 13.81% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | 1,789,617 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 129 | 1,842.86% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,962,486 | 103.75% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 283 | 0.03% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -5,543,678 | -61.22% | $0.00 |
| Logos Global Management LP | 31 Dec, 2025 | 0 | 65,000 | 6.95% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 489,282 | 20.24% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -748,381 | -43.76% | $0.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 0 | 188,326 | 10.66% | $0.00 |
| READYSTATE ASSET MANAGEMENT LP | 31 Dec, 2025 | 0 | -74,484 | -7.76% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 908,582 | 129.50% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 199,703 | 51.16% | $0.00 |
| Alyeska Investment Group, L.P. | 31 Dec, 2025 | 0 | 876,244 | 206.25% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 139,872 | 39.85% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 29,718 | 2.74% | $0.00 |